In the April (2) 2002, issue of Bone Marrow Transplantation Mele et al 1 report two cases of toxoplasmosis and perform a review of the literature. Their extensive review effort is to be congratulated and probably includes most of the case reports or small case series reported during the period analyzed. The authors state that they found 110 cases of toxoplasmosis (again, mostly case reports or small case series) up to December 2000. However, they fail to cite and include in their review the studies published in this matter by the European Group for Blood and Marrow Transplantation Infectious Diseases Working Party (EBMT-IDWP). In the year 2000, the EBMT-IDWP described first the frequency of toxoplasmosis and strategy policies in 52 EBMT centers 2 and later published the detailed description of 41 cases observed during a 5-year period in 15 of these centers. 3 Most importantly, the EBMT-IDWP proposed a set of definitions of the diagnostic certainty of toxoplasmosis infections and disease (see Table 1 ). These definitions are now used within the registry to report in detail cases of toxoplasmosis in patients registered in the EBMT. Reporting the degree of certainty in which a case of toxoplsmosis has been diagnosed is important, since many cases can be classified only as possible or probable cases, and definite cases are often diagnosed only at autopsy. As an example, the first case described by Mele et al would be classified as a probable Toxoplasma disease, while the second case would be a definite case based on post-mortem findings only. In the review performed by these authors, however, they make no mention to the degree of certainty of the diagnosis in the individual reports, so the reader cannot be certain how many cases of possible, probable and definite disease are described.
Additionally, the authors perform statistical analyses comparing the characteristics of patients diagnosed during life vs post mortem. Such an analysis may be misleading, since their data set is not derived from a cohort of consecutive patients from a single or from multiple institutions, but rather from published reports. Undoubtedly, in such analyses there is a strong publication bias that must be taken into account when interpreting the results (in addition to the diagnostic uncertainty of many cases, as described above). As an example, the authors stress that disseminated infection was more common in cases diagnosed post mortem, and at the same time they conclude that mortality was higher in disseminated than cerebral toxoplasmosis. This statistical result is inevitable, since most cases of disseminated infection (80% according to the authors) were diagnosed at autopsy and not during life, which biases the mortality towards disseminated infections.
Finally, the authors mention that PCR may improve the rapid diagnosis of toxoplasmosis and improve outcome. The EBMT-IDWP 4 has also analyzed this matter. In fact, we have warned that the lack of standardized PCR will make individual studies or case reports difficult to compare unless a quality control for PCR is set up. 4 The EBMT-IDWP is currently prospectively analyzing the usefulness of PCR in blood to monitor Toxoplasma reactivation in blood after allogeneic hematopoietic stem cell transplantation, where the quality of the PCR tests used is also monitored. Table 1 EBMT-IDWP definitions for toxoplasmosis after hematopoietic stem cell transplantation (from Martino et al 3 )
Rodrigo Martino and Catherine Cordonnier for the European Group for Blood and Marrow Transplantation Infectious Diseases Working Party (EBMT-IDWP).
Toxoplasmosis disease Definite toxoplasmosis Histologic or cytologic demonstration of tachyzoites in tissue samples obtained either by biopsy, bronchoalveolar lavage (BAL) or at autopsy. Isolation of the parasite by culture in these samples would be evidence of the disease Probable toxoplasmosis (PCR-documented)
Clinical and radiologic evidence suggestive of organ involvement plus at least one positive PCR test from blood, CSF and/or BAL, but no histologic confirmation and absence of another pathogen which may explain the findings Possible toxoplasmosis (Imaging-documented) CT or MRI highly suggestive of CNS toxoplasmosis (as considered by each hospital's neuroradiologists) and response to antitoxoplasma therapy, but no laboratory evidence of toxoplasmosis and absence of another pathogen which may explain the findings Toxoplasmosis infection
Positive PCR in blood in a patient without any evidence of organ involvement or seroconversion for Toxoplasma gondii after transplant in a previously seronegative patient (with or without fever)
